Skip to search formSkip to main contentSkip to account menu

MS 325

Known as: MS-325 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

gadofosveset trisodium

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
3D‐liver perfusion MRI with the MS‐325 blood pool agent: A noninvasive protocol to asses liver fibrosis
To evaluate a 1.5T magnetic resonance imaging (MRI) protocol, including a dedicated acquisition sequence and a postprocessing… 
2011
2011
DCE-MRI using small-molecular and albumin-binding contrast agents in experimental carcinomas with different stromal content.
2011
2011
Gd complexes of macrocyclic diethylenetriaminepentaacetic acid (DTPA) biphenyl-2,2'-bisamides as strong blood-pool magnetic resonance imaging contrast agents.
We report the synthesis of macrocyclic DTPA conjugates of 2,2'-diaminobiphenyl and their Gd complexes of the type [Gd(L)(H(2)O… 
Highly Cited
2007
Highly Cited
2007
Protein binding to lanthanide(III) complexes can reduce the water exchange rate at the lanthanide.
The GdIII-based magnetic resonance imaging contrast agent MS-325 targets the blood protein serum albumin, resulting in an… 
Highly Cited
2006
Highly Cited
2006
A Summary of Safety of Gadofosveset (MS-325) at 0.03 mmol/kg Body Weight Dose: Phase II and Phase III Clinical Trials Data
Objective:We sought to summarize the Phase II and Phase III clinical trials safety data for gadofosveset (Vasovist, MS-325), a… 
2006
2006
MR-koronarangiographie mit MS-325, einem Blood-Pool-Kontrastmittel : Vergleich einer Inversion Recovery Steady-State Free Precession und einer Inversion Recovery Fast Low Angle Shot Sequenz in…
PURPOSE: To compare the signal-to-noise and contrast-to-noise ratio as well as the image quality of 3D inversion recovery steady… 
2003
2003
Albumin‐binding MR blood pool agents as MRI contrast agents in an intracranial mouse glioma model
Intravenous MRI contrast agents are commonly used to improve the detection of intracranial tumors and other central nervous… 
2002
2002
B22956/1, a new intravascular contrast agent for MRI: first administration to humans--preliminary results.
Highly Cited
2002
Highly Cited
2002
Interstitial MR lymphography with MS-325: characterization of normal and tumor-invaded lymph nodes in a rabbit model.
OBJECTIVE The aim of our study was to evaluate the performance of a new blood-pool contrast agent, MS-325, in depicting regional… 
2000
2000
MS-325 EPIX.
EPIX is developing MS-325 (AngioMARK), an intravascular magnetic resonance contrast agent for use in the imaging of blood vessels… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)